Sugi Predict

Sugi Predict / Compounds / SCHEMBL2445366

SCHEMBL2445366

SCHEMBL2445366

C=CN(CCC)C(=O)CCCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.42
▸ CES2 O00748 4/20 0.41
▸ CES1 P23141 4/20 0.41
▸ TSHR P16473 4/20 0.41
▸ EPHX2 P34913 2/20 0.41
▸ KDM5A P29375 4/20 0.40
▸ KDM4C Q9H3R0 3/20 0.40
▸ AKR1B1 P15121 1/20 0.40
▸ KDM5C P41229 1/20 0.40
▸ KDM5B Q9UGL1 1/20 0.40
▸ PHF8 Q9UPP1 3/20 0.39
▸ PPARG P37231 4/20 0.39
▸ PPARD Q03181 4/20 0.39
▸ PPARA Q07869 4/20 0.39
▸ GPR84 Q9NQS5 3/20 0.39
▸ HDAC11 Q96DB2 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ SLC22A6 Q4U2R8 1/20 0.39
▸ SLC22A8 Q8TCC7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2447450 0.98 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2442886 0.98 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2441774 0.98 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2447538 0.98 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2445110 0.94 ALDH1A1 (0.48) FAAHALDH1A1CES2CES1TSHR
SCHEMBL11325370 0.91 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2947298 0.91 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL8079065 0.91 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL28060856 0.91 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR
SCHEMBL2946449 0.91 FAAH (0.47) FAAHALDH1A1CES2CES1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 — — US claimed
US-20170356877-A1 POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2017-12-14 — — US claimed
US-9671367-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2017-06-06 — — US claimed
US-20140209461-A1 Poly and Copoly(N-vinylamide)s and Their Use In Capillary Electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2014-07-31 — — US claimed
EP-2053067-B1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS LLC (US) 2011-09-14 — — EP claimed
CN-101724216-A Poly and copolyn(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS 2010-06-09 — — CN claimed
US-20100051461-A1 Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis Life Technologies Corporation (US) 2010-03-04 — — US claimed
CN-100567339-C (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2009-12-09 — — CN claimed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 — — EP claimed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 — — EP claimed
CN-1816573-A (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2006-08-09 — — CN claimed
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 — — EP claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 — — US claimed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 — — WO claimed
CN-117986814-A Antibacterial biodegradable expanded beads, preparation method thereof, expanded bead molded body and application thereof 中国石油化工股份有限公司 2024-05-07 — — CN disclosed
CN-117946489-A Composite antibacterial agent, blown film, preparation method and application thereof, antibacterial biodegradable polyester composition, polyester material and preparation method 中国石油化工股份有限公司 2024-04-30 — — CN disclosed
US-20240118238-A1 COMPOSITIONS AND KITS COMPRISING INTERPENETRATING POLYMER NETWORK FOR CAPILLARY ELECTROPHORESIS HONGENE BIOTECH CORPORATION 2024-04-11 — — US disclosed
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 — — EP disclosed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 — — US disclosed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL FAAH 4303/4885ALDH1A1 3357/4885CES2 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.